Evaluation of comprehensive annual care plans by pharmacists in Alberta for patients with complex conditions
| Autor: | Ross T. Tsuyuki, Jasjeet K. Minhas-Sandhu, Dean T. Eurich, Candace Necyk, Jeffrey A. Johnson |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Population MEDLINE Pharmacist Pharmacology (nursing) Pharmacy Pharmacists 030226 pharmacology & pharmacy Alberta Physician visit 03 medical and health sciences 0302 clinical medicine Health care Ambulatory Care Humans Medicine 030212 general & internal medicine education Pharmacology education.field_of_study business.industry Emergency department 3. Good health Hospitalization Family medicine Ambulatory Emergency Service Hospital business |
| Zdroj: | Journal of the American Pharmacists Association. 60:1029-1036.e1 |
| ISSN: | 1544-3191 |
| DOI: | 10.1016/j.japh.2020.08.025 |
| Popis: | To characterize the population of patients who received a pharmacist-billed comprehensive annual care plan (CACP) in Alberta and to evaluate any changes in health care use for such patients, including physician visits, hospitalizations, and emergency department (ED) visits.We used administrative data from Alberta Health to identify all individuals in Alberta who received a pharmacist CACP between July 1, 2012, and March 31, 2015. Two control patients were identified for each CACP patient, matched on age, sex, provider, date of service, and qualifying conditions. Controlled interrupted time series analyses were used to evaluate changes in physician visits, all-cause and ambulatory care-sensitive condition (ACSC)-related hospitalizations, and ED visits in the 12 months before and after the CACP index date.Between July 1, 2012, and March 31, 2015, 188,640 pharmacy CACPs were billed in Alberta. Of these, 137,178 CACP patients were matched to 241,658 control patients. Those who received a CACP were associated with an overall decrease in all-cause hospitalizations, ACSC-related ED visits, and physician visits (181, 144, and 1206 events per 10,000 people, respectively, P0.05) compared with controls. However, among those who received a CACP, all-cause ED visits and ACSC-related hospitalizations increased by 40.1 and 8 visits per 10,000, respectively (P0.05), compared with controls.The uptake of the pharmacy CACP remuneration model has been substantial since 2012. Overall, the CACP philosophy of a single yearly assessment has demonstrated limited impact on major health care use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|